12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Eyegate Pharmaceuticals (NASDAQ:EYEG) stock increased by 25.64% to $3.92 during Monday's after-market session. The company's market cap stands at $27.8 million.
Reviva Pharma Stock Is Trading Higher After Maxim Initiated With Buy, Target Price Of $10
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) is trading higher with around 60k in session volume.
Maxim Group Initiates Coverage On Reviva Pharmaceuticals with Buy Rating, Announces Price Target of $10
Maxim Group analyst Jason McCarthy initiates coverage on Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy rating and announces Price Target of $10.
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 19)
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
Monday morning, 285 companies reached new 52-week lows.
60 Biggest Movers From Yesterday
Gainers
Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related logistics assets.
Reviva: Developing Next-Generation Antipsychotic Drug
Schizophrenia is the most common psychotic disease with a global prevalence in about 1% of the population, affecting approximately 3.5 million people in the U.S. and 20 million globally.